NCT05816356: To Study the Oral Bioavailability of a New Combination Formation of Decitabine and Tetrahydrouridine in Healthy Males |
|
|
| Recruiting | 1 | 10 | US | Decitabine, DEC, Tetrahydrouridine, THU | EpiDestiny, Inc., Worldwide Clinical Trials | Healthy | 05/23 | 10/23 | | |